Publication | Open Access
Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial
39
Citations
21
References
2022
Year
EudraCT 2016-000958-36; ClinicalTrials.gov NCT02722447.
| Year | Citations | |
|---|---|---|
Page 1
Page 1